ADA Scientific Sessions 2026 Abstract·6 JunHM17321, a Novel UCN2 Analog, Improves Weight Loss Quality in Combination with Amylin Analogs in DIO RatsExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2026 Abstract·6 JunCardiorenal Protective Effects of a CRFR2-Selective UCN2 Analog, HM17321, in Spontaneously Hypertensive Rats (SHR)Experiments in animalsInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunHM17321, a CRFR2 Selective UCN2 Analog, Prevents Muscle Loss and Functional Decline in Sarcopenic MiceExperiments in miceSarcopeniaPaper
ADA Scientific Sessions 2025 Abstract·13 JunA Novel CRFR2 Selective UCN2 Analog, HM17321, Facilitates Weight Loss and Improves Body Composition across Animal Models of ObesityExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunA Novel CRFR2-Selective UCN2 Analog, HM17321, Improves Glycemic Control across Multiple Preclinical ModelsExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunRobust Antiobesity Effect and Mechanistic Insights of HM15275, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist in Animal Model of ObesityExperiments in animalsInterventionsPaper